Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Lymphocytic Leukaemia: A Review of Methods to Model Disease Outcomes and Estimate Utility
Crossref DOI link: https://doi.org/10.1007/s40273-014-0187-1
Published Online: 2014-07-13
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Marsh, Kevin
Xu, Peng
Orfanos, Panagiotis
Gordon, James
Griebsch, Ingolf
Text and Data Mining valid from 2014-07-13